Enhanced expressions of matrix metalloproteinase (MMP)-2 and –9 and vascular endothelial growth factors (VEGF) and increased microvascular density in the endometrial hyperplasia of women with anovulatory dysfunctional uterine bleeding
Authors:
- Caixia QiCQCaixia Qi
- Jun LinJLJun Lin
- 1 May 2010
- journal article
- Published by Elsevier in Fertility and Sterility
- Vol. 93 (7) , 2362-2367
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Hysterectomy Compared With Endometrial Ablation for Dysfunctional Uterine BleedingObstetrics & Gynecology, 2007
- Expression of vascular endothelial growth factor and assessment of microvascular density with CD 34 and endoglin in proliferative endometrium, endometrial hyperplasia, and endometrial carcinomaInternational Journal of Gynecological Cancer, 2007
- Endometrial bleedingHuman Reproduction Update, 2007
- Matrix Metalloproteinase-2 and -9 Expression Correlated with Angiogenesis in Human AdenomyosisGynecologic and Obstetric Investigation, 2006
- Microvascular density, vascular endothelial growth factor A, and its receptors in endometrial blood vessels in patients with menorrhagiaFertility and Sterility, 2005
- Matrix Metalloproteinases and Their Tissue Inhibitors in the Developing Neonatal Mouse Uterus1Biology of Reproduction, 2004
- Gelatinases A and B (MMP-2 and MMP-9) in endometrial cancer—MMP-9 correlates to the grade and the stageGynecologic Oncology, 2004
- Focal Expression and Final Activity of Matrix Metalloproteinases May Explain Irregular Dysfunctional Endometrial BleedingThe American Journal of Pathology, 2004
- Angiogenesis, vascular endothelial growth factor and the endometriumHuman Reproduction Update, 1998
- Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells.Journal of Clinical Investigation, 1997